KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 1 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $146,000 | +9.0% | 42,915 | +20.0% | 0.00% | 0.0% |
| Q2 2018 | $134,000 | -60.5% | 35,765 | -56.9% | 0.00% | -66.7% |
| Q1 2018 | $339,000 | -19.7% | 82,915 | -8.6% | 0.00% | -25.0% |
| Q4 2017 | $422,000 | -21.7% | 90,715 | +19.5% | 0.00% | -33.3% |
| Q3 2017 | $539,000 | -2.7% | 75,915 | -0.8% | 0.01% | -14.3% |
| Q2 2017 | $554,000 | +35.1% | 76,565 | +15.0% | 0.01% | +40.0% |
| Q1 2017 | $410,000 | +35.8% | 66,565 | +29.1% | 0.01% | 0.0% |
| Q4 2016 | $302,000 | +10.2% | 51,565 | +0.1% | 0.01% | 0.0% |
| Q3 2016 | $274,000 | -49.8% | 51,515 | -37.6% | 0.01% | -54.5% |
| Q2 2016 | $546,000 | +175.8% | 82,530 | +95.0% | 0.01% | +120.0% |
| Q1 2016 | $198,000 | -8.8% | 42,315 | -1.5% | 0.01% | -16.7% |
| Q4 2015 | $217,000 | +41.8% | 42,944 | -1.1% | 0.01% | +50.0% |
| Q3 2015 | $153,000 | -99.9% | 43,415 | +64.0% | 0.00% | -33.3% |
| Q2 2015 | $264,121,000 | +62340.0% | 26,465 | -20.4% | 0.01% | -25.0% |
| Q1 2015 | $423,000 | -99.9% | 33,265 | +10.6% | 0.01% | -11.1% |
| Q4 2014 | $425,420,000 | +41.5% | 30,065 | +37.5% | 0.01% | +50.0% |
| Q3 2014 | $300,644,000 | +41.5% | 21,865 | +58.3% | 0.01% | +20.0% |
| Q2 2014 | $212,475,000 | – | 13,815 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $3 | 0.00% |